Baxter International Inc. (BAX)
NYSE·Healthcare·Medical - Instruments & Supplies
$18.05
-2.41%
Mkt Cap $9.45B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $2.82B | $2.97B | +5.28% | $0.53 | $0.44 | -16.98% | — | — |
| Q4 2025 Oct 30, 2025 | $2.82B | $2.83B | +0.36% | $0.60 | $0.69 | +15.00% | — | — |
| Q3 2025 Jul 31, 2025 | $2.88B | $2.81B | -2.29% | $0.60 | $0.59 | -1.67% | — | — |
| Q2 2025 May 1, 2025 | $2.59B | $2.63B | +1.45% | $0.48 | $0.55 | +13.75% | — | — |
| Q1 2025 Feb 20, 2025 | $2.67B | $10.64B | +297.83% | $0.53 | $0.58 | +9.85% | — | — |
| Q4 2024 Nov 8, 2024 | $3.85B | $2.70B | -29.84% | $0.78 | $0.80 | +2.56% | — | — |
| Q3 2024 Aug 6, 2024 | $3.75B | $3.81B | +1.52% | $0.66 | $0.68 | +2.72% | — | — |
| Q2 2024 May 2, 2024 | $3.55B | $3.59B | +1.08% | $0.61 | $0.65 | +7.08% | — | — |
| Q1 2024 Feb 8, 2024 | $3.80B | $3.88B | +2.29% | $0.86 | $0.88 | +2.33% | — | — |
| Q4 2023 Nov 2, 2023 | $3.69B | $3.71B | +0.38% | $0.66 | $0.68 | +3.03% | — | — |
| Q3 2023 Jul 27, 2023 | $3.80B | $3.71B | -2.46% | $0.59 | $0.55 | -6.78% | — | — |
| Q2 2023 Apr 27, 2023 | $3.60B | $3.65B | +1.33% | $0.48 | $0.59 | +22.92% | — | — |
| Q1 2023 Feb 9, 2023 | $3.77B | $3.89B | +3.18% | $0.94 | $0.88 | -6.38% | — | — |
| Q4 2022 Oct 27, 2022 | $3.77B | $3.77B | +0.19% | $0.82 | $0.82 | +0.00% | — | — |
| Q3 2022 Jul 28, 2022 | $3.88B | $3.75B | -3.41% | $0.88 | $0.87 | -1.14% | — | — |
| Q2 2022 Apr 28, 2022 | $3.68B | $3.71B | +0.79% | $0.80 | $0.93 | +16.25% | — | — |
| Q1 2022 Feb 17, 2022 | $3.30B | $3.51B | +6.50% | $1.03 | $1.04 | +0.97% | — | — |
| Q4 2021 Oct 28, 2021 | $3.23B | $3.23B | -0.08% | $0.94 | $1.02 | +8.51% | — | — |
| Q3 2021 Jul 29, 2021 | $3.11B | $3.10B | -0.38% | $0.74 | $0.80 | +8.11% | — | — |
| Q2 2021 Apr 29, 2021 | $2.89B | $2.95B | +1.90% | $0.65 | $0.76 | +16.92% | — | — |